Susquehanna International Group
SXTC icon

Susquehanna International Group’s China SXT Pharmaceuticals SXTC Stock Holding History

Susquehanna International Group’s Portfolio SXTC Stock Details SXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1
Closed -$94K – 13911
2022
Q1 		$94K Buy
+1
New +$155K ﹤0.01% 11958
2021
Q4 		– Hold
0
– – – 11681
2021
Q1 		– Hold
0
– -$6K – 12834
2020
Q4 		– Hold
0
– – – 10928
2019
Q4 		– Hold
0
– -$19K – 10606
2019
Q3 		– Hold
0
– – – 9958

Other funds holding SXTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Susquehanna International Group's SXTC Position: Q2 2022 in Review

Susquehanna International Group sold out of China SXT Pharmaceuticals (SXTC) in Q2 2022, closing a stake of 1 share — an estimated $94K sold.

Susquehanna International Group first reported a position in SXTC in Q1 2022 and held it in 1 quarter. The position peaked at $94K in Q1 2022. 1 fund tracked by Wall St. Rank holds SXTC as of Q2 2022.

  • Susquehanna International Group reported no remaining China SXT Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Susquehanna International Group sold 1 China SXT Pharmaceuticals share in Q2 2022, an estimated $94K.
  • Susquehanna International Group first reported a position in China SXT Pharmaceuticals in Q1 2022 and held it in 1 quarter.
  • Susquehanna International Group's China SXT Pharmaceuticals position peaked at $94K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held China SXT Pharmaceuticals as of Q2 2022.

Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.